-
A selection of posters presented during IHC in September are now uploaded in the IHS Poster Library20/11/2019
A selection of posters presented during IHC in September are now uploaded in the IHS Poster Library.
If you would like your poster to be included please email to Carol Taylor
-
Apply today to learn about all different headache disorders and gain an academic degree14/11/2019
Application is now open for the 3rd Master in Headache Disorders (MHD) at the University of Copenhagen. This is a 2-year part time program on all headache disorders following which you will receive an Academic Master Degree.
In MHD1 from 2016-2018 17 Masters graduated with excellence and at present 23 MHD2 students will graduate in June 2020. They come from 17 different countries from The Philippines, Pakistan, Iran, Europe and USA. The students background qualifications in MHD2 are a great interest and experience in clinical management of pain and headache. The group consists of 16 neurologists, 1 GP, 4 nurses, 1 physiotherapist and 1 osteopath.
In a world with limited resources education is the key, especially within the headache field, where there is a significant unmet need for academic education.
For more information please click HERE
-
Three short-stay scholars from India and Serbia attended IHC and visited three centres in Dublin05/11/2019
Three young clinicians and researchers, two from India one from Serbia, attended iHEAD, IHC and then spent up to 6 weeks in headache centres in Dublin. Read about their experiences below.
If you are a young doctor from a developing country, and would like to apply for the 2020 Short-stay scholar programme, please visit the IHS website later in the year when the application process will open. Or join IHS today as an Associate Member to make sure you receive notification!
-
The late-breaking abstracts are now published in Cephalalgia24/10/2019
The IHC 2019 late-breaking abstracts are now published in Cephalagia and available on the IHS website in the Congress section
-
IHS sent two Visiting Professors to Kathmandu to teach on headache medicine11/10/2019IHS sent two Visiting Professors to Kathmandu to teach on headache medicine
-
IHCD-3 translations into Bulgarian and Romanian are now published in the ICHD-3 section of the website21/09/2019
We are pleased to publish translations of the ICHD-3 in Bulgarian and Romanian - click here to visit the ICHD-3 section of the website.
ICHD-3 is also available in Brazilian Portuguese, Chinese, French, German, Japanese, Korean, Portuguese and Spanish.
Thanks to the dedicated work of members of the local Affiliate Member Societies who undertake this task on behalf of IHS.
-
Awards were presented to the top two Excellence Tournament presentations and top posters13/09/2019
Juniors Headache Science Excellence Tournament
Basic science: Zachariah Bertels - Differential effects of mu and delta opioid receptor agonists in models of chronic migraine-associated pain and aura
Clinical: Mohammad A.-M. Al-Karagholi - Opening of ATP sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine
Posters
Best poster (selected by the Juniors Group): James Mitchell - Detailed intra-cranial pressure monitoring in idiopathic intracranial hypertension probes diurnal and postural variability,
Best poster (selected by the Delegates): Hashmat Ghanizada - PACAP27 induces migraine-like attacks in migraine patients,
Other top posters
Raeburn Forbes - What proportion of anti-CGRP antibody therapy for migraine is contextual (placebo) effect?
Ditte Zhang - Blood glucose levels increase during spontaneous attacks of migraine with and without aura
Lawrence Robbins - CGRP monoclonal antibodies: first year results, controversies, and management Issues
-
Lars Edvinsson had the pleasure to give Fumihiko Sakai his award in Dublin10/09/2019
The 2019 IHS Special Recognition Award, awarded to individuals who have contributed greatly to the Society, was awarded to Professor Fumihiko Sakai of Saitama International Headache Center, Japan.
Lars Edvinsson, IHS President, presented the award during the IHC 2019 Opening Ceremony, 5 September 2019.
-
Scholars attended iHEAD, IHC 2019 and will spend up to 6 weeks in hospitals close to Dublin, Ireland10/09/2019
Three IHS Short-stay scholarships were awarded to young clinicians / researchers to attend the International Headache Academy (iHEAD), IHC 2019 and then spend up to 6 weeks in Irish headahce centres, close to Dublin. The successful applicants were:
Gunjan Kumar, India. Host institution: Tallaght Hospital, Dublin – mentor: Sean O'Dowd
Agaath Hedina Manickam, India. Host institution: Beaumont Hospital, Dublin – mentor: Martin Ruttledge
Ana Podgorac, Serbia. Host institution: Mater Hospital, Dublin – mentor: Roisin Lonergan
Congratulations to all, and many thanks to the Irish centre mentors for welcoming them into their hospitals, and in particular to Martin Ruttledge, Co-Chair of IHC, who made the arrangements with the local centres.
-
Following the elections earlier in 2019, four new members joined the IHS Board on 6 September10/09/2019
Following the elections earlier this year, a new President-elect and three new Trustees joined the IHS Board of Trustees following the AGM on 6 September
President-elect: Cristina Tassorelli, Italy
Trustees: Fayyaz Ahmed, UK; Gianluca Coppola, Italy; Alexandra Sinclair, UK
Welcome to all
And many thanks to our retiring Trustees: David Dodick (Past-President), Anna Ambrosini, Rigmor Jensen, Gisela Terwindt (Elected Trustees), Mark Braschinsky, Chin-Sang Chung, Bronwyn Jenkins, Ingela Nilsson-Remahl (Co-opted Trustees)
-
Recent retirements and appointments09/09/2019
Following the IHC in Dublin, several Committee Chairs have retired, and new and re-appointments made.
Classification - Jes Olesen retires after three decades as Chair during which three versions of the International Classification of Headache Disorders (ICHD) have been published. Many thanks to Jes for his tireless work on behalf of IHS and the Classification. Peter Goadsby has been appointed as his successor.
Clinical Trials – following her success in the IHS Presidential election, Cristina Tassorelli has stepped down as Chair. Gisela Terwindt will assume the role and continue the excellent work of the committee in developing and publishing international guidelines.
Education – Allan Purdy will continue as Chair of Education until 2021. As this is a key committee, with many activities, the Board agreed to appoint a Co-Chair to assist with the work. Henrik Schytz has been appointed and will work alongside Allan for the next 2 years.
Membership – Luiz Paolo de Queiroz has served 8 years as Chair and now retired. Thanks to Luiz Paolo for all his work for the committee. Anne Ducros has been appointed as Chair of this committee.
Re-appointments – each IHS Committee Chair serves a 4-year term, which is renewable for a further 4 years. Re-appointments at IHC 2021 are: Arne May – Cephalalgia Editorial; Anna Andreou – Electronic Media.
IHS is immensely grateful to all Committee and Special Interest Group Chairs for the dedication to the role and support of IHS.
-
Wonderful to see our young fellows presenting their research in Dublin07/09/2019
Recent IHS Fellows, Doga Vurali, Inge Mulder, Olivier Brock and Kuan-Po Peng had the opportunity to present their Fellowship research at the IHC 2019 in Dublin on 6 September. Congratulations to all for a very successful session!
News Archive
-
Headache in India
28/02/2019
Headache Update 2018 was held in Mumbai in December 2018 with the aim to update Indian headache specialists and neurologists on the recent advances in headache medicine. Faculty included key international headache specialists and IHS leaders. Dr K.Ravishankar was the Course Director and reports on the meeting.
-
4th Annual International Headache Symposium in Israel
31/12/2018
The 4th Annual International Headache Symposium in Israel will take place in Tel Aviv, Israel, on 9 January 2019
The symposium will run under the auspices of IHS - for more information see the IHSI website
-
IHS-GPAC thought-leaders meet in New York
08/10/2018
This weekend in New York members of the IHS-GPAC Steering and Core Committees held a strategy workshop to prepare for the global launch of the IHS Global Patient Advocacy Coalition (IHS-GPAC) to work on patient advocacy efforts for people with migraine and other headache disorders. This inspirational group representing 12 worldwide countries brainstormed over 2 days to initiate a pioneering mission. One member of the group said 'It is a great and huge honour to participate in this adventure which I am sure will end in amazing tools for patients and physicians, and the public to equalise all needs in headaches around the world'. To use an old adage: If not us, who; if not now, when?
Photos of the workshop can be viewed below.
-
Congratulations to IHC prize winners
31/10/2017
IHS congratulates IHC 2017 Trainees Excellence Tournament and poster prize winners
Trainees Excellence Tournament
Clinical Presentation
Julia Hebestreit - Topiramate inhibits thalamic activity during trigeminal pain in humans
Scientific Presentation
Inge Loonen - Functional characteristics of non-invasively optogenetically induced CSD in FHM1 mutant mice
Poster prizes
T&R SIG choice
Altered brainstem anatomy in migraine
Noemi Meylakh, Flavia Di Pietro, Kasia Marciszewski, Vaughan Macefield, Luke Henderson, Paul MaceyPeople's choice
Infusion of calcitonin gene-related peptide provokes cluster headache attacks
Anne Luise Vollesen, Agneta Snoer, Rasmus Paulin Beske, Song Guo, Rigmor Højland Jensen, Messoud Ashina, Jan Hoffmann -
Jes Olesen recognition for ICHD leadership
19/09/2017
IHS recognises the enormous contribution of Professor Jes Olesen in leading the development of ICHD. ICHD has provided the basis for advances in the clinical and biological understanding of headache disorders and continues to facilitate the progress in treatment.
-
Chris Diener receives IHS Special Recognition Award
18/09/2017
Professor Hans-Christoph Diener is seen receiving his award from IHS President, Professor David Dodick during the IHC 2017 Opening Ceremony on 7 September 2017
Photo: JON BENJAMIN PHOTOGRAPHY
-
IHC 2017 Presidential Symposium
15/09/2017
VANCOUVER, B.C., SEPTEMBER 7-10, 2017 — The theme of the 2017 Congress of the International Headache Society, “New Horizons in Headache,” nods to both the location of the conference in Vancouver, B.C., and to the event’s focus on the new frontier of headache medicine.
“This unprecedented event in headache medicine marks the turning point for a group of diseases that have endured a severe lack of understanding, damaging stigma, historic underfunding for research, and a painfully slow pace of treatment advances,” said Dr. David Dodick, President of the International Headache Society and Co-Chair of the Congress, in his welcoming remarks Sept. 7.
The Presidential Symposium, kickstarting the 2017 Congress of the International Headache Society, follows the first-ever Global Patient Advocacy Symposium, a one-day intensive connecting leaders in headache medicine with public health organizations, patient advocacy groups and other interdisciplinary allies to establish mutual international patient support goals.
Awards and Recognitions
The ceremony opened by honoring the accomplished life of Ninan Mathew (1937-2015), founder of the Houston Headache Clinic and former president of the International Headache Society. Prof. Jes Olesen was the recipient of the IHS Lifetime Achievement Award for his outstanding accomplishments with the Danish Headache Center, which are exemplary in the field. In addition, Dr. Hans-Christoph Diener received the IHS Special Recognition Award for his integrity, ethics, and professionalism, all of which have earned him remarkable respect amongst colleagues around the world.
Accomplishments
Since the last Congress in 2015, the organization has made several key developments, reaching critical goals that include to sustain and grow global education, build a global network of researchers, and to mentor and develop future leaders, including the development of a women’s leadership program. In addition, the IHS just surpassed the largest membership base in the history of the organization. At the Symposium, Dodick announced that IHS has developed and launched a full, open access companion journal to Cephalalgia, called Cephalalgia Reports. The new journal will include original research papers, review articles, clinical perspectives, case reports, CME articles, technical reports and more.
New Horizons
Called the most exciting field in neurology, and the most groundbreaking moment in headache medicine, new advancements are indeed on the horizon. Highlighting four key breakthrough areas in the field, International Headache Congress began with a Presidential Symposium including presentations to address the new horizons in headache imaging, translational research, genetics and novel treatment targets, presented by Drs. Todd Schwedt, Frank Porecca, Michel Ferrari and Peter Goadsby, respectively.
Global Patient Advocacy Call to Action
In an effort to build an emphasis on patient-centric care, the 2017 Congress was preceded by the first ever Global Patient Advocacy Summit. To continue the momentum, a motion to globalize migraine patient advocacy has been made through the forming of the Global Patient Advocacy Coalition (GPAC). Objectives of the GPAC include country-specific research surrounding the formation of a global migraine approach to advocacy, resources to develop local outreach, evaluation of local initiatives, refinement of tactics and needs assessment.
The Congress brings together hundreds of leaders from the International Headache Society’s membership for four days of lectures, networking, peer education and expert panels focused on the world of headache science, education and management at the unique Vancouver Convention Centre. IHC2017 will include plenary sessions, an extensive poster display and in-depth scientific presentations showcasing basic and clinical research that that promises an exciting future for headache medicine.
“We have the collective brain trust, commitment, and influence in this room today to change all of that for the hundreds of millions who suffer with disabling headache around the globe by building awareness, raising support, delivering education, and improving access to care,” says Dr. Dodick.
-
IHS awards Special Recognition and Life Membership
09/09/2017
Congratulations to Dr Hans-Christoph Diener, past IHS President, on receiving the IHS Special Recognition Award in 2017.
Congratuations also to Dr Alan Rapoport for receiving his Life Membership certificate as he transitions off the Board having served his term as Immediate Past-President.
-
Cephalalgia Award Lecture presented at IHC
09/09/2017
Congratuations to Thomas Linman and colleagues who have received the Cephalalgia Award Lecture for their article 'Circulating endothelial microparticles in female migraineurs with aura'. Cephalalgia 2015;35:88-94
His presentation will take place at the IHC 2017 this evening.
-
Welcome to the new IHS Trustees
08/09/2017
Following the IHS Annual General Meeting Dr Lars Edvinsson steps into the role of President.
We welcome Dr Messoud Ashina as IHS President-elect and Dr Mario Peres, Dr Patricia Pozo-Rosich and Dr Todd Schwedt as elected Trustees.
Many thanks to the Trustees who are leaving the Board for their tireless efforts on behalf of the society:
Alan Rapoport - Past-President
Rami Burstein
Fayyaz Ahmed
Werner Becker
Mamoru Shibata
Alessandro Zagami -
First-Ever Global Patient Advocacy Summit
06/09/2017
SEPTEMBER 6, 2017, 8:00 AM PDT: VANCOUVER, B.C. — For the first time in the history of headache medicine, the top representatives from 49 International Headache Society member groups will gather for a one-day summit to identify the most essential global goals for the field with an emphasis on patient support. The Global Patient Advocacy Summit (GPAS), held on Sept. 6, 2017, kicks off the four-day, 18th Congress of the International Headache Society, and represents a groundbreaking interdisciplinary effort between doctors, researchers, government agencies and patient advocates to design a blueprint to close gaps in headache diagnosis, research and treatment.
“Individuals living with migraine bear multiple burdens. Not only is their disease potentially debilitating, it’s also invisible, misunderstood and deprived of the necessary investment in research that’s proportional to its devastating scope,” said Dr. David Dodick, President of the International Headache Society and Co-Chair of the Congress. “Migraine is identified by the World Health Organization as the third most disabling medical illness on the planet. The Global Patient Advocacy Summit represents a focused, organic partnership between doctors, patients and public health organizations to rectify that inequity, and make progress in the field of headache medicine."
Through a series of panels and interorganizational sessio
ns, the goal of the one-day summit is to identify opportunities for patient advocacy around the globe, and the avenues by which leading professional medical societies, patient advocacy groups, and industry leaders can help facilitate and support these efforts. “There is a staggering 37 million people living with migraine in the United States alone. Many of those people have never had their symptoms taken seriously or even addressed by a headache specialist,” said Meghan Buzby, Executive Director of the American Migraine Foundation, a partner organization presenting at the summit. “The more resources we can dedicate to education and driving public awareness, the more effective we will be at giving millions of people the tools they desperately need to advocate for their health and overall well-being.”
In addition to patient advocacy, one of the key meeting initiatives is to identify mechanisms to expand and improve patient access to healthcare services and treatment. New research has led to the development of groundbreaking therapies that could change the lives of millions of migraine patients around the world. Still, even in developed countries, migraine and headache research lacks access to publicly available research dollars. The massive and disproportionate lack of funding, relative to the disease's prevalence and its overall economic burden, has resulted in a glacial pace of treatment advances—a problem the summit attendees pledge to overcome in time.
The Global Patient Advocacy Summit represents a robust commitment to headache medicine and a uniform approach to a patient-centric offensive against the disabling disease. Elevating the profile of migraine, educating patients on advocacy opportunities, strategizing solutions to overcome barriers to treatment and organizing awareness campaigns for employers, governments and the general public are key agenda items the summit will address.
At the conclusion of the one-day event, participants will collaboratively generate a white paper and a strategic blueprint for migraine patient advocacy that will be published in Cephalalgia, the International Headache Society’s medical journal.
Participating organizations include the World Health Organization, the U.S. Food and Drug Administration, various nonprofit organization
s such as the American Migraine Foundation, American Academy of Neurology and other leading patient advocacy groups and national medical agencies from around the globe. About the International Headache Society:
The International Headache Society is the world’s leading membership organization for all whose professional commitment, whatever their discipline, is to helping people whose lives are affected by headache. As a charity, the purpose of IHS is to advance headache science, education, and management, and promote headache awareness worldwide. Activities include publication of Cephalalgia, the biennial International Headache Congress, developing guidelines, the international headache classification, educating the next generation of headache specialists worldwide, online education materials and offering grants and fellowships to young physicians worldwide. For more information about the IHS, visit their website: http://www.ihs-headac
he.org About Migraine/Headache:
Migraine is the third most prevalent and sixth most disabling medical illness in the world. Despite the more than 1 billion people affected by migraine around the globe, it is vastly underrecognized and undertreated, and there remains tremendous disparity in patient access to education, healthcare services, and drug, device, and non-pharmacological treatments. Individuals who experience migraine have symptoms that include nausea, sensitivity to light and/or odors, skin sensitivity, fatigue, mood change, dizziness, difficulty concentrating, neck pain and changes in vision, including seeing spots, stars, lines, flashing lights and zigzag lines. The risk of other serious diseases is significantly higher in those with migraine, including stroke, epilepsy, depression, anxiety and chronic pain. Despite this, only one of every three people talk with a doctor about their migraine attacks and of those, only half get the right diagnosis. There is also a massive shortage of specialists focusing on migraine, with one specialist for every 65,000 individuals living with migraine, which worsens the problem.
Media Inquiries:
Lizzie Tufano
(708) 705-0822
lizzie@yakketyyak.com
318 W. Adams Ste 1607, Chicago, IL 60606 -
MRF announces 2015 award recipients
18/12/2015
The Migraine Research Foundation is pleased to announce the recipients of the research grants awarded for 2015. The grants will help research into new migraine biomarkers, identifying new treatments from traditional Chinese medicine, studying New Daily Persistent Headache, and more. For information on the awardees see HERE.
-
New Editor-in-Chief for Cephalalgia
18/09/2015
IHS is very pleased to announce that Arne May will succeed David Dodick as Editor-in-Chief of Cephalalgia from January 2016.
Arne has served on the IHS Board of Trustees since June 2013, and as an Associate Editor of Cephalalgia since March 2009. He is currently head of one of the largest headache outpatient clinics in Germany, based at the University Clinic in Hamburg (UKE). His scientific interest in headache is long-standing, and he has published papers and book chapters on genetics, epidemiology, physiology and pathophysiology of the trigeminovascular system, headache classification and phenotype, as well as functional imaging.
Arne said "This is a huge opportunity and I am very honoured to be appointed. All my vigour will be to keep Cephalalgia where it has so successfully been led by David Dodick and former Editors: the best journal to publish the best headache science available".
-
IHS Visiting Professors in Bulgaria and Estonia
12/08/2015
Alan Rapoport and Nina Latysheva attended the 14th Bulgarian National Congress in Varna, Bulgaria, in May as IHS Visiting Professors. Read the meeting report here.
Messoud Ashina and Alan Rapoport presented at the 2015 Estonian Headache Society annual meeting - Mark Braschinsky reports.
Slide presentations from the Estonian meeting, and also the Moroccan and Azerbaijan Visiting Professor meetings, are available in the Learning Centre/Visiting Professors.
-
Visiting Professor Reports - Azerbaijan, Morocco
28/07/2015
The IHS Visiting Professor initiative sends headache specialists as representatives of IHS to attend regional meetings, or teach at a headache centre, in countries that might need or want increased headache education and motivation but where without financial support attendance of an international specialist would not be possible.
We report on two recent Visiting Professor projects in Azerbaijan and Morocco.
- Report on 1st Pan-African meeting 28/07/2015
- 5th ARCH meeting report 28/07/2015
-
ICHD-3-beta Portuguese translation
28/07/2014
A Portuguese translation of the ICHD-3-beta is now available.
This work has been completed by a team of Portuguese headache specialists, including José Pereira Monteiro (Coordinator), José Rocha Barros, Paula Esperança, Gabriela Fernandes, Helena Gens, Raquel Gil Gouveia, Isabel Luzeiro, Jorge Machado, Isabel Pavão Martins, Fernando Matias, Maria Manuela Palmeira, Elsa Parreira, Carlos Fontes Ribeiro, Alfredo Sá and Lívia Sousa.
The translation will be published in the official Journal of the Portuguese Neurological Society (Sinapse) to enable dissemination of this highly relevant information for daily clinical practice among our Portuguese-speaking colleagues, over the world.
The translation was sponsored by the Portuguese Headache Society and the Portuguese Neurological Society.
-
'Headache and Pain' - book published
10/03/2014
Headache and other types of pain have some common characteristics concerning pain generation and chronicity. But some distinct pathophysiological processes are unique to the headache. This book explores pain mechanisms, diagnosis, and management of headache and other chronic pain through sessions of a joint symposium of IASP and the International Headache Society. This book, edited by Ralf Baron (IASP) and Arne May (IHS), represents the current state of scientific discussions of the respective fields in both pain areas.
See the IASP website for more information
-
ICHD-3-beta slide kit now available
17/02/2014
- ICHD-3-beta Spanish translation 17/02/2014
- Additional ICHD-3-beta slides now available 09/09/2013
-
ICHD-3-beta slides now available
06/09/2013
-
Cephalalgia App released
20/06/2013
The Cephalalgia App is now available for download through the iTunes store.
Simply click here to see the Cephalalgia app in iTunes.
The App will be freely available until the end of August, when it will become an IHS membership benefit.
- ICHD-3 beta now published 17/06/2013
- Dr Marcia Wilkinson, one of the first Editors of Cephalalgia, has died aged 93 05/02/2013